IR-Med Inc.

OTCPK:IRME Stock Report

Market Cap: US$58.8m

IR-Med Valuation

Is IRME undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of IRME when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate IRME's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate IRME's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for IRME?

Key metric: As IRME is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for IRME. This is calculated by dividing IRME's market cap by their current book value.
What is IRME's PB Ratio?
PB Ratio29375x
BookUS$2.00k
Market CapUS$58.75m

Price to Book Ratio vs Peers

How does IRME's PB Ratio compare to its peers?

The above table shows the PB ratio for IRME vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average10.1x
MDNC Medinotec
22.4xn/aUS$58.7m
NVNO enVVeno Medical
1.2x32.9%US$59.1m
BEAT HeartBeam
15.7x48.4%US$65.9m
RBOT Vicarious Surgical
1x-3.8%US$53.3m
IRME IR-Med
29375x86.4%US$58.8m

Price-To-Book vs Peers: IRME is expensive based on its Price-To-Book Ratio (29375x) compared to the peer average (6x).

Price to Book Ratio vs Industry

How does IRME's PB Ratio compare vs other companies in the US Medical Equipment Industry?

28 CompaniesPrice / BookEstimated GrowthMarket Cap
ADGM Adagio Medical Holdings
0.4xn/aUS$29.07m
RVP Retractable Technologies
0.2xn/aUS$17.55m
MHUA Meihua International Medical Technologies
0.1xn/aUS$16.93m
LFWD Lifeward
0.5x65.0%US$16.30m
IRME 9,999xIndustry Avg. 2.5xNo. of Companies28PB0246810+
28 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Book vs Industry: IRME is expensive based on its Price-To-Book Ratio (29375x) compared to the US Medical Equipment industry average (2.5x).

Price to Book Ratio vs Fair Ratio

What is IRME's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

IRME PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio29375x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate IRME's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Elevance Health

US$92.2b

Operates as a health benefits company in the United States.

ELV

US$403.60

7D

-0.8%

1Y

-15.9%

Centene

US$29.8b

Operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States.

CNC

US$60.35

7D

2.8%

1Y

-18.7%

electroCore

US$64.1m

A commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally.

ECOR

US$9.92

7D

-27.1%

1Y

80.4%